Immunovant
IMVT
#2553
Rank
HK$53.84 B
Marketcap
HK$260.20
Share price
-0.12%
Change (1 day)
41.10%
Change (1 year)

Market capitalization of Immunovant (IMVT)

Market cap: HK$53.84 Billion

As of November 2026 Immunovant has a market cap of HK$53.84 Billion. This makes Immunovant the world's 2553th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Immunovant from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$53.84 B31.31%
2025HK$41.00 B46.94%
2024HK$27.90 B-41.37%
2023HK$47.59 B165.69%
2022HK$17.91 B134.5%
2021HK$7.64 B-78.2%
2020HK$35.05 B418.89%
2019HK$6.75 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Immunovant was reported to be:

HK$53.84 Billion
by Nasdaq info icon info icon
HK$53.84 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
HK$6.23 B-88.42%๐Ÿ‡บ๐Ÿ‡ธ USA